ConductScience.org, home

Paper950308

[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity].

Rüegger A and 6 others. Helv Chim Acta, 1976. Cited by 270 papers, by iCite.

Cite this record

ConductScience Library. [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Papers, record 950308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/950308

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity].
PubMed
Journal
Helv Chim Acta
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
270
iCite
Relative citation ratio, by iCite
7.48
iCite
Revised in PubMed
2009-11-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rüegger AA
2Kuhn MM
3Lichti HH
4Loosli HRH R
5Huguenin RR
6Quiquerez CC
7von Wartburg AA

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
Fungal ProteinsMajor topic
Peptides, CyclicMajor topic

Cited by79

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 270 citations.

PMIDTitleJournalYearIn PapersSource
42760444Safety profiles of calcineurin inhibitor-related infections in the pediatric population: a real-world pharmacovigilance analysis.Eur J Pediatr2026https://conductscience.org/library/papers/42760444PubMed
42744847Cyclosporin A triggers a RIG-I-mediated interferon response through multiple cellular processes.Sci Rep2026https://conductscience.org/library/papers/42744847PubMed
42390747Automating Plasmid Construction for High-Throughput Heterologous Expression of Fungal Gene Clusters.Methods Mol Biol2026https://conductscience.org/library/papers/42390747PubMed
42256226Discovery of a fungal Tc toxin complex and functional mycoserpin through a novel two-by-two comparative genomics approach.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42256226PubMed
41403028Paraisariamides: Cycloheptapeptide Toxins from Entomopathogenic Fungi (Paraisaria spp.) That Inhibit Total Protein Synthesis.J Nat Prod2026https://conductscience.org/library/papers/41403028PubMed
40770076Immobilized acyl-transfer molecular reactors enable the solid-phase synthesis of sterically hindered peptides.Nat Chem2025https://conductscience.org/library/papers/40770076PubMed
40406348LC-MS/MS-guided discovery of japonamides C and D, two new cyclohexadepsipeptides, from the Nicotiana tabacum-derived endophytic fungus Aspergillus japonicus TE-739D.Front Microbiol2025https://conductscience.org/library/papers/40406348PubMed
40093757Fungi: Pioneers of chemical creativity - Techniques and strategies to uncover fungal chemistry.IMA Fungus2025https://conductscience.org/library/papers/40093757PubMed
39480090Cyclophilin A facilitates HIV-1 integration.J Virol2024https://conductscience.org/library/papers/39480090PubMed
38943005A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.EMBO Rep2024https://conductscience.org/library/papers/38943005PubMed
38930843Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation.Molecules2024https://conductscience.org/library/papers/38930843PubMed
38786701Transcriptome Sequencing and Analysis of Trichoderma polysporum Infection in Avena fatua L. Leaves before and after Infection.J Fungi (Basel)2024https://conductscience.org/library/papers/38786701PubMed
38542872Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers.Molecules2024https://conductscience.org/library/papers/38542872PubMed
38487927Natural Products That Contain Higher Homologated Amino Acids.Chembiochem2024https://conductscience.org/library/papers/38487927PubMed
37843371Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.J Virol2023https://conductscience.org/library/papers/37843371PubMed
36762908Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes.J Med Chem2023https://conductscience.org/library/papers/36762908PubMed
36567735Development of the force field for cyclosporine A.Biophys Physicobiol2022https://conductscience.org/library/papers/36567735PubMed
35877744Asperopiperazines A and B: Antimicrobial and Cytotoxic Dipeptides from a Tunicate-Derived Fungus Aspergillus sp. DY001.Mar Drugs2022https://conductscience.org/library/papers/35877744PubMed
35696348Tolypocladamides A-G: Cytotoxic Peptaibols from Tolypocladium inflatum.J Nat Prod2022https://conductscience.org/library/papers/35696348PubMed
35500108Tolypocladamide H and the Proposed Tolypocladamide NRPS in Tolypocladium Species.J Nat Prod2022https://conductscience.org/library/papers/35500108PubMed

See all 79 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/950308

GET https://conductscience.org/api/papers/v1/950308/cited_by?page=2